Acesso livre
Acesso livre

Covid-19 (Temas de Saúde Pública)

Amplo estudo nos EUA mostra que a vacinação contra Covid-19 durante a gestação é segura.

17 Fev, 2022 | 14:32h

Covid-19: Vaccination during pregnancy is safe, finds large US study – The BMJ

Estudo original: Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth — Eight Integrated Health Care Organizations, United States, December 15, 2020–July 22, 2021 – CDC Morbidity and Mortality Weekly Report

Conteúdos relacionados:

COVID vaccines safely protect pregnant people: the data are in.

COVID-19 vaccination in pregnancy—number needed to vaccinate to avoid harm.

A case-controlled study showed Covid-19 vaccination during early pregnancy was not associated with increased risk of first-trimester miscarriage.

Editorial: Covid-19 treatments and vaccines must be evaluated in pregnancy.

AstraZeneca vaccination not linked to reduced fertility rates and adverse birth outcomes.

Cohort study: Vaccinated pregnant patients had 90% lower risk of severe or critical Covid-19 compared with unvaccinated pregnant patients.

Two observational studies suggest spontaneous abortion is not increased following COVID-19 mRNA vaccination during pregnancy.

Study shows high effectiveness of the Pfizer mRNA COVID-19 vaccine in pregnancy.

5 Crucial Things to Know About COVID-19 Vaccines and Pregnancy.

CDC Guidance: Pregnant people should be vaccinated against COVID-19.

ACOG and SMFM Recommend COVID-19 Vaccination for Pregnant Individuals – “ACOG encourages its members to enthusiastically recommend vaccination to their patients.”

Cohort study: Pfizer/BioNTech COVID vaccine associated with 78% lower risk of Covid-19 in pregnancy.

Artigo | Tuberculose em tempos de COVID-19.

15 Fev, 2022 | 11:50h

Tuberculosis in times of COVID-19 – Journal of Epidemiology & Community Health

Conteúdos relacionados:

Covid-19’s Devastating Effect on Tuberculosis Care — A Path to Recovery.

Global tuberculosis progress reversed by COVID-19 pandemic.

WHO Report: Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic.

How COVID is derailing the fight against HIV, TB and malaria.

How COVID hurt the fight against other dangerous diseases

World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis

WHO: Benefits of continuing to provide life-saving HIV services outweigh the risk of COVID-19 transmission by 100 to 1

Tuberculosis and Covid-19: Fighting a deadly syndemic

Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study

Por que a maioria das pessoas com COVID não precisa ser testada pelos próximos 30 dias, mesmo em caso de reexposição?

15 Fev, 2022 | 11:49h

Why don’t most people with COVID need to test for another 30 days, even if they’re re-exposed? – The Conversation

Metanálise de estudos clínicos randomizados | Vacinas para prevenir COVID-19.

15 Fev, 2022 | 11:43h

Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials – PLOS One

Covid-19 – Quarta dose de vacina: quem precisa dela e por quê?

15 Fev, 2022 | 11:40h

Covid-19: Fourth vaccine doses—who needs them and why? – The BMJ

Novavax afirma que vacina proteica funciona para crianças a partir dos 12 anos de idade.

14 Fev, 2022 | 16:16h

Novavax says protein vaccine works for kids as young as 12 – Associated Press

Comunicado de imprensa: Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial

Conteúdos relacionados:

Randomized trial with nearly 30.000 individuals showed Novavax vaccine was safe and had an overall efficacy of 90.4% against symptomatic infections.

RCT: Novavax vaccine conferred 89.7% protection against symptomatic SARS-CoV-2 infection and 100% protection against hospitalizations or deaths.

Opinion | The mRNA vaccines are extraordinary, but Novavax is even better.

(Press release – not published yet) Novavax COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease.

RCT: Novavax vaccine is 49.4% effective against B.1.351 SARS-CoV-2 variant.

[Press release – not published yet] Novavax reports 96% efficacy against original strain of COVID-19, 86% efficacy against B.1.1.7 variant, and 55% efficacy against B1.351 variant

New COVID-19 vaccines: here’s how the promising Novavax and Johnson & Johnson jabs work

Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant

Pfizer e FDA recuam em relação ao plano para agilizar a avaliação de vacinas contra Covid-19 em crianças menores de 5 anos.

14 Fev, 2022 | 16:14h

Pfizer and FDA pull back from plan to expedite review of Covid-19 vaccine in young children – STAT

Ver também:

COVID-19 vaccine for kids under 5 delayed as Pfizer extends trial – CIDRAP

Pfizer postpones FDA request for Covid vaccine for kids under 5 – NBC News

Covid-19: o que se sabe sobre as sublinhagens da Ômicron?

14 Fev, 2022 | 16:08h

Covid-19: What do we know about omicron sublineages? – The BMJ

Conteúdos relacionados:

We regret to inform you that we are now discussing subvariants – Vox

Sudden rise of more transmissible form of Omicron catches scientists by surprise.

Omicron’s sister variant spreads faster. So why did the one we call Omicron hit first?

[Preprint] Study suggests SARS-CoV-2 Omicron subvariants BA.2 is even more transmissible than the original variant.

BA.2 is like Omicron’s sister. Here’s what we know about it so far – The Conversation

 

Comentário no Twitter

 

Entrevista em áudio: Covid-19 como doença endêmica.

11 Fev, 2022 | 14:22h

Audio Interview: Covid-19 as an Endemic Disease – New England Journal of Medicine

Bebês nascidos durante o primeiro ano da pandemia tiveram um escore levemente menor em testes de avaliação de desenvolvimento.

11 Fev, 2022 | 14:21h

Comunicado de imprensa: Babies born during pandemic’s first year score slightly lower on a developmental screening test – Columbia University Irving Medical Center

Estudo original: Association of Birth During the COVID-19 Pandemic With Neurodevelopmental Status at 6 Months in Infants With and Without In Utero Exposure to Maternal SARS-CoV-2 Infection – JAMA Pediatrics

Editorial: Understanding the Effects of the Pandemic on Infant Development—The Preterm Problem

Comentários:

Covid-19: Babies born during the pandemic show slight development delays – The BMJ

Pandemic birth tied to poor development – CIDRAP

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.